Dilemmas in anticoagulation and use of inferior vena cava filters in venous thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical Oncologists and a review of the literature
Twenty percent of patients with Cancer Associated Thrombosis receive an inferior vena cava filter annually. Insertion is guided by practice guidelines, which do not specify or discuss the use of inferior vena cava filters in malignancy. Adherence to these guidelines is known to be variable. We aimed...
Main Authors: | Philip Craven, Ciara Daly, Nisha Sikotra, Tim Clay, Eli Gabbay |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-01-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894020953841 |
Similar Items
-
Inferior vena cava filters (IVCFs): a review of uses and application to international guidelines at a single Australian center; implications of venous thromboembolism associated with malignancy
by: Philip Craven, et al.
Published: (2018-05-01) -
Is it worth adding an inferior vena cava filter to anticoagulation in thromboembolic disease?
by: Alexandra Yunes
Published: (2017-06-01) -
Perforation of Inferior Vena Cava by Inferior Vena Cava Filter
by: Sarah Unterman, et al.
Published: (2013-03-01) -
Sarcoma de vena cava inferior Sarcoma of the vena cava inferior
by: Jorge Luis León Álvarez, et al.
Published: (2010-12-01) -
Inferior vena cava filters in the management of cancer-associated venous thromboembolism: a systematic review
by: Rachna Raman, et al.
Published: (2011-12-01)